You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ONT-380

Showing 1 - 25 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

Not yet recruiting
  • Metastatic Solid Tumor
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Dec 30, 2022

Breast Cancer Trial in United States (Tucatinib in Combination with Palbociclib and Letrozole)

Active, not recruiting
  • Breast Cancer
  • Tucatinib in Combination with Palbociclib and Letrozole
  • Tucson, Arizona
  • +5 more
Mar 8, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in Australia (Tucatinib, Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Albury, New South Wales, Australia
  • +11 more
May 22, 2022

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • Anaheim, California
  • +13 more
Aug 15, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

HER2 Positive Breast Cancers Trial in Canada, United States (Tucatinib (ONT-380), T-DM1)

Completed
  • HER2 Positive Breast Cancers
  • Birmingham, Alabama
  • +10 more
Sep 17, 2020

HER2 Positive Metastatic Breast Cancers Trial in United States (Tucatinib, Capecitabine, Trastuzumab)

Completed
  • HER2 Positive Metastatic Breast Cancers
  • Aurora, Colorado
  • +4 more
Jun 2, 2020

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Healthy Trial in Glendale (Tucatinib)

Completed
  • Healthy
  • Glendale, California
    PAREXEL International, Early Phase Clinical Unit - Los Angeles
Sep 3, 2019

HER2 Positive Breast Cancer Trial in Worldwide (Tucatinib, Trastuzumab, Pertuzumab)

Recruiting
  • HER2 Positive Breast Cancer
  • Phoenix, Arizona
  • +143 more
Jan 20, 2023

Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Not yet recruiting
  • Brain Metastases
  • HER2-positive Breast Cancer
  • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
  • (no location specified)
Jan 10, 2023

Cachexia Trial (AV-380)

Not yet recruiting
  • Cachexia
  • AV-380
  • (no location specified)
May 9, 2023

Postpartum Contraception Trial in Cairo (Copper T380 IUD ( Paragard 380 A ,CooperSurgical, Inc. © 2022) (classic technique),

Recruiting
  • Postpartum Contraception
  • Copper T380 IUD ( Paragard 380 A ,CooperSurgical, Inc. © 2022) (classic technique)
  • +2 more
  • Cairo, Egypt
    Kasr Alainy outpatient infertility clinic
Feb 23, 2023

Uterine Artery Doppler and Menstrual Changes After Insertion

Not yet recruiting
  • Intrauterine Contraceptive Device Complication
  • Copper intrauterine contraceptive device
  • LNG-IUS
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university Hospital
Aug 13, 2023

HER2-positive Breast Cancer Trial in Worldwide (tucatinib, , T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Mobile, Alabama
  • +262 more
Jan 26, 2023

Trial (Tucatinib)

No longer available
    • (no location specified)
    Feb 21, 2020

    Haemodynamic Instability Trial in Banha (dexmedetomidine plus ketamine, Dexmedetomidine)

    Recruiting
    • Haemodynamic Instability
    • Banhā, Qalubia, Egypt
      Benha university
    Jul 16, 2023

    Opioid-use Disorder Trial in New York (Naltrexone 380 MG)

    Active, not recruiting
    • Opioid-use Disorder
    • Naltrexone 380 MG
    • New York, New York
      Columbia University Medical Center
    Jul 1, 2022

    Periodontitis, Diabetes Trial in Rawalpindi (1ml of 1% metronidazole gel, 1ml of 2% minocycline gel, 1ml of combination of 1%

    Completed
    • Periodontitis
    • Diabetes Mellitus
    • 1ml of 1% metronidazole gel
    • +2 more
    • Rawalpindi, Punjab, Pakistan
      Islamic International Medical Collège, IIMC
    Aug 31, 2023

    IUD Trial (IUD)

    Not yet recruiting
    • IUD
    • IUD
    • (no location specified)
    Mar 8, 2022